Phosphoinositide 3-kinase in Health and Disease Volume 2 /

From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in pro...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Rommel, Christian. (Editor, http://id.loc.gov/vocabulary/relators/edt), Vanhaesebroeck, Bart. (Editor, http://id.loc.gov/vocabulary/relators/edt), Vogt, Peter K. (Editor, http://id.loc.gov/vocabulary/relators/edt)
Format: Electronic eBook
Language:English
Published: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2011.
Edition:1st ed. 2011.
Series:Current Topics in Microbiology and Immunology, 347
Subjects:
Online Access:https://doi.org/10.1007/978-3-642-14816-3
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first